Announcements Trials
Browse Landscape

Status

Completed 43Recruiting 24Terminated 11Unknown 8Active not recruiting 4Not yet recruiting 3Available 3Withdrawn 2Suspended 1

Sponsor Class

INDUSTRY 3

Study Type

Expanded_access 3

Sponsor

Cancer Type

Gastrointestinal 6Thoracic 4Gynecologic 4Genitourinary 4Sarcoma 3CNS 3Head & Neck 2Dermatologic 2Breast 2Lymphoid 1

Conditions

Neuroblastoma 6Glioblastoma 4Recurrence 3Pancreatic Neoplasms 3Head and Neck Neoplasms 3Stomach Neoplasms 2Pheochromocytoma 2Ovarian Neoplasms 2Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Brain Neoplasms 2Urinary Bladder Neoplasms 1Typical Teratoid Rhabdoid Tumor 1Thyroid Neoplasms 1Sarcoma 1Prostatic Neoplasms 1Paraganglioma 1Neurofibromatoses 1Neurofibroma, Plexiform 1Neuroectodermal Tumors, Primitive 1Meningioma 1Melanoma 1Medulloblastoma 1Lymphoma, Non-Hodgkin 1Hodgkin Disease 1Glioma 1Gastrointestinal Neoplasms 1Esophageal Neoplasms 1Colorectal Neoplasms 1Cholangiocarcinoma 1

Interventions

ulixertinib 1Proton Pump Inhibitors 1Hydrocortisone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Available × Pancreatic Neoplasms × CNS × Clear all
NCT04566393 2026-06-04

Expanded Access to Ulixertinib (BVD-523) in Patients With Advanced MAPK Pathway-Altered Malignancies

xCures

Available
CNSDermatologicGastrointestinalGenitourinaryGynecologicHead & NeckThoracic

Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Esophageal Neoplasms, Glioblastoma, Head and Neck Neoplasms, Carcinoma, Hepatocellular, Melanoma, Ovarian Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms, Thyroid Neoplasms, Colorectal Neoplasms, Cholangiocarcinoma

NCT05974410 2025-10-02

Expanded Access to Immunomodulatory AVM0703 for Solid Tumor and Blood Cancer Patients

AVM Biotechnology Inc

Available
BreastCNSGastrointestinalGenitourinaryGynecologicLymphoidSarcoma

Brain Neoplasms, Breast Neoplasms, Carcinoma, Squamous Cell, Glioblastoma, Hodgkin Disease, Lymphoma, Non-Hodgkin, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Sarcoma, Stomach Neoplasms

NCT06872489 2025-07-23

Expanded Access Protocol for the Use of SL-28 in the Treatment of Advanced Solid Tumors

Second Life Therapeutics

Available
CNSGastrointestinalHead & NeckThoracic

Carcinoma, Non-Small-Cell Lung, Gastrointestinal Neoplasms, Head and Neck Neoplasms, Neuroblastoma, Pancreatic Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡